Table 1.
CHR | Physical Position | SNP | P | FDR_BH | Allele A | Allele B | BETA | R2(%) |
---|---|---|---|---|---|---|---|---|
Male | ||||||||
scaffold2344_1 | 326,970 | AX-174702570 | 1.80E-07 | 0.02 | A | G | 67.9 | 5.59 |
scaffold2344_1 | 327,739 | AX-174961896 | 1.80E-07 | 0.02 | T | G | 67.9 | 5.59 |
scaffold2344_1 | 337,514 | AX-174407967 | 1.80E-07 | 0.02 | A | G | 67.9 | 5.59 |
scaffold2344_1 | 337,544 | AX-174402854 | 1.80E-07 | 0.02 | A | G | 67.9 | 5.59 |
scaffold4472_1 | 23,932 | AX-174929694 | 1.43E-06 | 0.12 | A | G | 41.84 | 4.00 |
scaffold4472_1 | 82,966 | AX-174547362 | 2.68E-06 | 0.20 | A | G | 45.29 | 5.25 |
scaffold2104_1 | 1,168,770 | AX-174734142 | 4.97E-06 | 0.25 | A | G | -48.47 | 7.40 |
scaffold2104_1 | 1,170,706 | AX-174706158 | 4.97E-06 | 0.25 | A | G | -48.47 | 7.40 |
scaffold4472_1 | 68,096 | AX-174783962 | 5.82E-06 | 0.25 | A | G | 43.11 | 5.41 |
scaffold70_3 | 2,788,947 | AX-174627015 | 5.98E-06 | 0.25 | A | G | 51.08 | 8.14 |
scaffold2021_1 | 491,659 | AX-174928167 | 6.47E-06 | 0.25 | T | C | 49.71 | 0.27 |
scaffold699_1 | 549,280 | AX-174555047 | 8.94E-06 | 0.32 | T | G | -50.34 | 0.26 |
Female | ||||||||
scaffold10_1 | 223,744 | AX-174845027 | 3.39E-06 | 0.56 | A | G | -19.78 | 2.10 |
scaffold1366_1 | 539,922 | AX-174891371 | 5.39E-06 | 0.56 | T | C | 68.75 | 0.87 |
scaffold1366_1 | 561,203 | AX-174570649 | 5.56E-06 | 0.56 | A | G | 68.94 | 0.29 |
scaffold923_1 | 123,435 | AX-174620133 | 9.60E-06 | 0.56 | T | C | -19.78 | 2.72 |
FDR False discovery rate
R2: phenotypic variance explained (PVE) by the significant SNP